Background: Multimorbidity is rising in low-and middle-income countries (LMICs). However,
the evidence on its epidemiology from LMICs settings is limited and the available literature …

Introduction: Substance use is an important risk factor for HIV, with both concentrated in
certain vulnerable and marginalized populations. Although their management differs, there …

Objective: To describe available models of HIV and noncommunicable disease (NCD) care
integration in sub-Saharan Africa (SSA). Design: Narrative review of published articles …

Objectives At present, data are limited on the comorbidity profiles associated with aging
people with HIV in the developing world, where most such people live. The aim of this study …

Abstract Background Non-communicable diseases (NCDs) contribute significantly to the
global disease burden, with low-and middle-income (LMICs) countries disproportionately …

Background Over the last decade, the Kenyan HIV treatment program has grown
exponentially, with improved survival among people living with HIV (PLHIV). In the same …

HIV in the antiretroviral therapy era is characterized by multimorbidity and the frequent
occurrence of HIV-associated non-AIDS chronic health conditions. Respiratory symptoms …

Objectives: Data on cardiovascular disease risks among HIV-infected patients taking
antiretroviral therapy (ART) over long periods of time are lacking in Sub-Saharan Africa …

Background Past studies have found a relationship between detectable HIV viral load and
non-communicable diseases (NCDs) in HIV-infected individuals on antiretroviral therapy in …

Introduction: The HIV-infected population is growing due to the increased accessibility of
antiretroviral therapy (ART) that extends the lifespan of people living with HIV (PLHIV). We …